OCUL
USDOcular Therapeutix Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$11.200
Kõrge
$11.355
Madal
$10.400
Maht
1.84M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
2.3B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
2.72M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target
TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans
Seotud aktsiad
DCOMP
Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A
HSIC
Henry Schein
OSK
Oshkosh Corporation (Holding Company)Common Stock
BWG
BrandywineGLOBAL Global Income Opportunities Fund Inc.
JELD
JELD-WEN Holding Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.